DermaSensor, Inc.
PrivateLast Round
Series B
Extension
Sep 9, 2026
Total Funding Raised
$47.31M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
DermaSensor, Inc. operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a Series B Extension round in September 2026.
DermaSensor, Inc. is a medical device company that has developed an FDA-cleared, AI-powered handheld device that uses optical spectroscopy to non-invasively assess suspicious skin lesions for melanoma, basal cell carcinoma, and squamous cell carcinoma.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Sensors, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DermaSensor, Inc. Comparables
Compare DermaSensor, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Veriskin | 85% | |
| Speclipse | 79% | |
| MetaOptima Technology | 78% |
For institutional investors. Book with your work email.
DermaSensor, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 9, 2026 | ||||
| Series B | Oct 2, 2025 | ||||
| Series A Extension | Jun 15, 2022 | ||||
| Series A | Jun 4, 2020 | ||||
| Series A Extension | Dec 18, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DermaSensor, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SternAegis Ventures | Series A |
| Ceros Capital Markets | Series A |
| Pier 70 Ventures | Series B |
| Wealthing VC Club | Series A Extension |
| Kern Venture Group | Series B |
| Ceros Capital Markets | Series A Extension |
| Miami Angels | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2026
$4M round completed.
- Aug 22, 2026
Monthly visitors grew 59% MoM, reaching 29.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 22, 2026
DermaSensor, Inc. is named a finalist in the 2026 Digital Health & AI Awards, with winners scheduled to be announced on Nov 16th '26, during HLTH 2026 in Nevada.
- partners_withSep 28, 2026
DermaSensor, Inc. partners with ContraCare under a distribution agreement announced on Sep 28th '26, with DermaSensor, Inc. supplying medical devices and ContraCare managing commercial distribution across Germany, Austria, and Switzerland.
- launchesSep 28, 2026
On Sep 28th '26, DermaSensor, Inc. commercially launches DermaSensor in Germany through a distribution agreement with ContraCare GmbH, bringing its AI-powered skin cancer risk detection technology to the market.
- partners_withSep 18, 2026
DermaSensor, Inc. partners with Medical Place, which is set to serve as DermaSensor, Inc.'s exclusive reseller to the Department of Veterans Affairs in the United States, opening another potentially significant market for the technology.
- receives_financingSep 9, 2026
DermaSensor, Inc. received financing of $1M in community investment round on Sep 9th '26.
For institutional investors. Book with your work email.
DermaSensor, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DermaSensor, Inc.'s valuation, stock price, and market status.
Is DermaSensor, Inc. a public or private company?
DermaSensor, Inc. is a private company.
What is the current stock price of DermaSensor, Inc.?
DermaSensor, Inc. is a private company, so its shares have no public market price. Caplight tracks DermaSensor, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DermaSensor, Inc. worth (valuation)?
Valuation information for DermaSensor, Inc. is not publicly available.
Can I buy DermaSensor, Inc. stock?
DermaSensor, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DermaSensor, Inc.'s last funding round?
DermaSensor, Inc.'s most recent funding round was Series B Extension on September 9, 2026.
Who are the main investors in DermaSensor, Inc.?
Key investors in DermaSensor, Inc. include SternAegis Ventures, Ceros Capital Markets.
Will DermaSensor, Inc. IPO soon?
No public IPO plans have been announced for DermaSensor, Inc..
How can I track DermaSensor, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in DermaSensor, Inc.'s shares on secondary markets.